BioCentury | Feb 17, 2021
Deals

Feb. 17 Quick Takes: Vir, GSK expand partnership; plus Nektar; ImmuneID, Imcyse, Provention-Huadong and Novartis-Gates

...ImmuneID with $17 millionImmuneID Inc. raised a $17 million venture round led by founding investor Longwood Fund...
...robotic automation and AI, was developed in the lab of Harvard Medical School’s Stephen Elledge. Longwood Fund...
BioCentury | Jan 25, 2021
Finance

TScan to bring five T cell therapies to the clinic by 2022 with $100M series C

...autoimmune diseases. Two undisclosed healthcare-focused funds also participated in the C round, as did existing investors Longwood Fund...
BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...Adage Capital, Sphera Healthcare and CaaS Capital. Returning investors from its $56 million series A are Longwood Fund...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...substantial limitations,” co-founder and President Aleks Radovic-Moreno told BioCentury. Radovic-Moreno is an entrepreneur in residence at Longwood Fund...
...partners: NoneNumber of employees: 10Funds raised: $52 millionInvestors: Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund...
BioCentury | Aug 21, 2020
Finance

CF Foundation’s Longwood incubator fund to push early tech toward CF

...therapies for cystic fibrosis  By stephen hansen, associate editor The Cystic Fibrosis Foundation’s partnership with Longwood Fund...
...co-founder Christoph Westphal will govern the fund.TARGETSCFTR – Cystic fibrosis transmembrane conductance regulator Stephen Hansen Cystic Fibrosis Foundation Longwood Fund Pulmonary Cystic...
BioCentury | Aug 7, 2020
Finance

Aug. 6 Quick Takes: More pressure on China’s U.S. listings; busy Editas; Athenex bestows royalty on Sagard; Longwood, CFF launch incubator and more

...Foothold Via Royalty Fund” ). CF Foundation, Longwood launch incubator The Cystic Fibrosis Foundation and Longwood Fund...
...the development of genetic therapies for CF by Longwood companies. The foundation, an LP in Longwood Fund...
...Cure agenda. It also may invest in seed rounds during a new company’s formation within Longwood Fund’s...
BioCentury | Jul 28, 2020
Finance

Founded by Dipp and Lum, growth firm Biospring to invest in services, tools, software

...Jennifer Lum around the intersection of life sciences and technology. Dipp is a co-founder of Longwood Fund...
BioCentury | Jul 23, 2020
Finance

Amid measured expansion, Longwood raises $170M for fifth fund

...Although Longwood Fund’s latest vehicle is more than twice the size of its prior fund, the 10-year-old...
...can expand slowly, but we don’t want to lose what makes us special.” David Steinberg, Longwood Fund...
...but he said the group includes endowments, foundations, strategic investors and family offices. Paul Bonanos, Associate Editor Longwood Fund...
BioCentury | Jun 18, 2020
Emerging Company Profile

Lassen emerges from Frazier with over $31M and a mAb for fibrosis and cancer

...Frazier led Lassen Therapeutics’ $31 million series A round, which had participation from Alta Partners, Longwood Fund...
...Tokyo:4901) Number of employees: 8 Funds raised: $31.5 million Investors: Frazier Healthcare Partners, Alta Partners, Longwood Fund...
BioCentury | Mar 31, 2020
Deals

Lilly gains rights to Sitryx’s two most advanced immunometabolic programs in four-target deal

...has been relatively quiet since that time. Its investors include SV Health Investors, Sofinnova Partners, Longwood Fund...
Items per page:
1 - 10 of 64
BioCentury | Feb 17, 2021
Deals

Feb. 17 Quick Takes: Vir, GSK expand partnership; plus Nektar; ImmuneID, Imcyse, Provention-Huadong and Novartis-Gates

...ImmuneID with $17 millionImmuneID Inc. raised a $17 million venture round led by founding investor Longwood Fund...
...robotic automation and AI, was developed in the lab of Harvard Medical School’s Stephen Elledge. Longwood Fund...
BioCentury | Jan 25, 2021
Finance

TScan to bring five T cell therapies to the clinic by 2022 with $100M series C

...autoimmune diseases. Two undisclosed healthcare-focused funds also participated in the C round, as did existing investors Longwood Fund...
BioCentury | Jan 7, 2021
Finance

Werewolf’s conditionally-activated cancer therapies draw $72M series B, partnering interest

...Adage Capital, Sphera Healthcare and CaaS Capital. Returning investors from its $56 million series A are Longwood Fund...
BioCentury | Oct 23, 2020
Emerging Company Profile

Be Bio: bringing the B to cell therapy

...substantial limitations,” co-founder and President Aleks Radovic-Moreno told BioCentury. Radovic-Moreno is an entrepreneur in residence at Longwood Fund...
...partners: NoneNumber of employees: 10Funds raised: $52 millionInvestors: Atlas Venture, RA Capital Management, Alta Partners, Longwood Fund...
BioCentury | Aug 21, 2020
Finance

CF Foundation’s Longwood incubator fund to push early tech toward CF

...therapies for cystic fibrosis  By stephen hansen, associate editor The Cystic Fibrosis Foundation’s partnership with Longwood Fund...
...co-founder Christoph Westphal will govern the fund.TARGETSCFTR – Cystic fibrosis transmembrane conductance regulator Stephen Hansen Cystic Fibrosis Foundation Longwood Fund Pulmonary Cystic...
BioCentury | Aug 7, 2020
Finance

Aug. 6 Quick Takes: More pressure on China’s U.S. listings; busy Editas; Athenex bestows royalty on Sagard; Longwood, CFF launch incubator and more

...Foothold Via Royalty Fund” ). CF Foundation, Longwood launch incubator The Cystic Fibrosis Foundation and Longwood Fund...
...the development of genetic therapies for CF by Longwood companies. The foundation, an LP in Longwood Fund...
...Cure agenda. It also may invest in seed rounds during a new company’s formation within Longwood Fund’s...
BioCentury | Jul 28, 2020
Finance

Founded by Dipp and Lum, growth firm Biospring to invest in services, tools, software

...Jennifer Lum around the intersection of life sciences and technology. Dipp is a co-founder of Longwood Fund...
BioCentury | Jul 23, 2020
Finance

Amid measured expansion, Longwood raises $170M for fifth fund

...Although Longwood Fund’s latest vehicle is more than twice the size of its prior fund, the 10-year-old...
...can expand slowly, but we don’t want to lose what makes us special.” David Steinberg, Longwood Fund...
...but he said the group includes endowments, foundations, strategic investors and family offices. Paul Bonanos, Associate Editor Longwood Fund...
BioCentury | Jun 18, 2020
Emerging Company Profile

Lassen emerges from Frazier with over $31M and a mAb for fibrosis and cancer

...Frazier led Lassen Therapeutics’ $31 million series A round, which had participation from Alta Partners, Longwood Fund...
...Tokyo:4901) Number of employees: 8 Funds raised: $31.5 million Investors: Frazier Healthcare Partners, Alta Partners, Longwood Fund...
BioCentury | Mar 31, 2020
Deals

Lilly gains rights to Sitryx’s two most advanced immunometabolic programs in four-target deal

...has been relatively quiet since that time. Its investors include SV Health Investors, Sofinnova Partners, Longwood Fund...
Items per page:
1 - 10 of 64